| Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma. | |
| | |
MedLine Citation:
|
PMID: 9329575 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Between January 1986 and June 1992 56 patients with cervical carcinoma were treated with cytostatic drugs in our department. In all patients showing primary response to therapy, the SCC and CEA levels fell rapidly to normal after one or two cycles. In contrast, clinical remission was not obtained in those patients with levels which remained high or rose again following an initial decrease. Using tumor markers, treatment can be individualized so that, cases of therapy failure or further tumor progression can be detected early and the patient can be spared the severe side effects of treatment. |
| | |
Authors:
|
W Meier; P Stieber; U Hasholzner; L Baumgartner; A Fateh-Moghadam |
Related Documents
:
|
8535215 - Soluble icam-1 in hodgkin's disease: a promising independent predictive marker for surv... 15646835 - Serum cathepsin h as a potential prognostic marker in patients with colorectal cancer. 17786705 - Hyperammonemia encephalopathy: an important cause of neurological deterioration followi... 20541245 - Evaluation of serum ca-125 levels for preoperative counseling in endometrioid endometri... 14753595 - Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumor... 22331945 - Phase ii study of imatinib in advanced chordoma. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Anticancer research Volume: 17 ISSN: 0250-7005 ISO Abbreviation: Anticancer Res. Publication Date: 1997 Jul-Aug |
Date Detail:
|
Created Date: 1997-10-29 Completed Date: 1997-10-29 Revised Date: 2005-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8102988 Medline TA: Anticancer Res Country: GREECE |
Other Details:
|
Languages: eng Pagination: 2959-62 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Klinikum Grosshadern, University of Munich, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antigens, Neoplasm
/
blood* Carcinoembryonic Antigen / blood Carcinoma, Squamous Cell Female Humans Neoplasm Recurrence, Local / blood* Prognosis Serpins* Tumor Markers, Biological / blood* Uterine Cervical Neoplasms / blood*, mortality |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, Neoplasm; 0/Carcinoembryonic Antigen; 0/Serpins; 0/Tumor Markers, Biological; 0/squamous cell carcinoma-related antigen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical c...
Next Document: Clinical value of CYFRA 8/18 and TPS in the diagnosis and follow up of invasive breast cancer.